A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
Developing therapeutics to address neurological disabilities like Alzheimers disease and Downs Syndrome.
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Noninvasive stroke and vascular disorder treatment device
Small molecule, peptide and peptidomimetic modulators
The company has a novel platform of disease-modifying regenerative small molecules, particularly relevant to neurodegenerative ...
Neurologic Treatment - 'Convection Enhanced Delivery'
Neuroendovascular therapeutic devices
NeuroPointDX, through its compound safety screening division Stemina Biomarker Discovery, has developed the leading metabolomics platform for ...
The company investigates small molecules to find treatments for neurodegenerative disorders like Alzheimers’disease.
Neurodegenerative Disease Treatments
Therapix Biosciences (OTCQB: THXBY; TASE: THXBY) is an Israel-headquartered emerging specialty pharmaceutical company developing unique Cannabinoid technologies in treatment of central nervous ...